Industry News
David Penington to headline AusMedtech Melbourne conference dinner
Emeritus Professor David Penington AC will deliver an insightful address about his experiences within the medical industry and how to translate medical research into products as part of the AusMedtech 2013 conference dinner on Wednesday 15 May 2013. [ + ]
Japan’s I’rom buys into IDT Australia
Japanese site management organisation (SMO) I’rom Holdings will pay $2m for a 19% stake in CMO IDT Australia, and the pair will combine their clinical trial site offerings in Australasia. [ + ]
Submission to reduce clinical trial insurance in NSW
Contributions are being sought for a submission to NSW Health to reduce clinical trial indemnity insurance in the state. [ + ]
Researchers banking on getting your thoughts
Menzies Research Institute Tasmania, an institute of the University of Tasmania, is calling for the public to voice their opinion on a Tasmanian biobank to inform an ongoing research project. [ + ]
Novogen finds new anticancer candidates
Novogen’s (ASX:NRT) anticancer program has identified two second-generation drug candidates, showing promise in pancreatic cancer and melanoma, and one will be fast-tracked to the clinic. [ + ]
Controlling lung inflammation in asthmatics
The biggest study of its type in the world is investigating a possible new treatment for asthma sufferers. [ + ]
GTG settles licensing dispute in US
Genetic Technologies (ASX:GTG) has resolved a dispute surrounding a licence to its non-coding DNA patents first awarded in 2004. [ + ]
Govt taking applications for precincts initiative
The Australian life science industry has a chance to apply to be one of up to 10 Industry Innovation Precincts - consortia of businesses and universities aimed at fostering R&D and competitiveness. [ + ]
United Bioresearch appointed Australian distributor for Abiocode
United Bioresearch has announced its appointment as the Australian distributor for Californian-based Abiocode. [ + ]
Biotron releases more data from HCV trial
Biotron has presented some pharmacokinetic data from its phase IIa trial of BIT225 in HCV, showing no evidence of drug resistance growth. [ + ]
pSivida partner gets new PDUFA date for Iluvien
The US FDA will decide by 17 October whether to approve pSivida (ASX:PVA) licensee Alimera’s NDA for Iluvien in diabetic macular edema. [ + ]
Concern over plan to remove or limit patent extensions
AusBiotech has made a submission in response to the Pharmaceutical Patent Review’s (PPR) Draft Report, stating its disappointment at the options provided under recommendation 5 to remove or reduce Australia’s patent extension provisions. [ + ]
Screening for Alzheimer’s disease
The development of a blood test for the early detection of Alzheimer’s disease takes a step forward. [ + ]
Study reveals ancient microbial feasting
The first-ever snapshot of primitive organisms eating each other has been found in ancient fossils examined by a team of scientists at The University of Western Australia (UWA). [ + ]
High-speed discovery helps measure greenhouse gases from space
Scientists have discovered how to measure greenhouse gases 200,000 times faster as the result of research by an award-winning PhD student from The University of Western Australia (UWA) and a US team. [ + ]
